nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—Thalidomide—leprosy	0.146	0.176	CbGbCtD
Oxcarbazepine—CYP3A5—Rifampicin—leprosy	0.141	0.17	CbGbCtD
Oxcarbazepine—CYP2C19—Thalidomide—leprosy	0.118	0.142	CbGbCtD
Oxcarbazepine—CYP3A5—Dapsone—leprosy	0.117	0.141	CbGbCtD
Oxcarbazepine—CYP2C19—Rifampicin—leprosy	0.114	0.137	CbGbCtD
Oxcarbazepine—CYP2C19—Dapsone—leprosy	0.0941	0.113	CbGbCtD
Oxcarbazepine—CYP3A4—Rifampicin—leprosy	0.0551	0.0664	CbGbCtD
Oxcarbazepine—CYP3A4—Dapsone—leprosy	0.0455	0.0548	CbGbCtD
Oxcarbazepine—Ligament sprain—Dapsone—leprosy	0.00984	0.058	CcSEcCtD
Oxcarbazepine—Status epilepticus—Thalidomide—leprosy	0.0054	0.0318	CcSEcCtD
Oxcarbazepine—Proteinuria—Dapsone—leprosy	0.00283	0.0167	CcSEcCtD
Oxcarbazepine—Hyporeflexia—Thalidomide—leprosy	0.0028	0.0165	CcSEcCtD
Oxcarbazepine—Protein urine present—Dapsone—leprosy	0.00279	0.0164	CcSEcCtD
Oxcarbazepine—Altered state of consciousness—Thalidomide—leprosy	0.00276	0.0162	CcSEcCtD
Oxcarbazepine—Gastric ulcer—Thalidomide—leprosy	0.00219	0.0129	CcSEcCtD
Oxcarbazepine—Toothache—Thalidomide—leprosy	0.00209	0.0123	CcSEcCtD
Oxcarbazepine—Psoriasis—Thalidomide—leprosy	0.00203	0.0119	CcSEcCtD
Oxcarbazepine—Hypothyroidism—Thalidomide—leprosy	0.00198	0.0117	CcSEcCtD
Oxcarbazepine—Neuralgia—Thalidomide—leprosy	0.00183	0.0108	CcSEcCtD
Oxcarbazepine—Interstitial lung disease—Thalidomide—leprosy	0.0018	0.0106	CcSEcCtD
Oxcarbazepine—Nystagmus—Thalidomide—leprosy	0.00178	0.0105	CcSEcCtD
Oxcarbazepine—Metrorrhagia—Thalidomide—leprosy	0.00178	0.0105	CcSEcCtD
Oxcarbazepine—Psychotic disorder—Dapsone—leprosy	0.00176	0.0104	CcSEcCtD
Oxcarbazepine—Stupor—Thalidomide—leprosy	0.00171	0.01	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Dapsone—leprosy	0.00161	0.00951	CcSEcCtD
Oxcarbazepine—Muscular weakness—Dapsone—leprosy	0.00159	0.00938	CcSEcCtD
Oxcarbazepine—Pancreatitis—Dapsone—leprosy	0.00153	0.00901	CcSEcCtD
Oxcarbazepine—Acne—Thalidomide—leprosy	0.00151	0.00891	CcSEcCtD
Oxcarbazepine—Proteinuria—Thalidomide—leprosy	0.00145	0.00853	CcSEcCtD
Oxcarbazepine—Protein urine present—Thalidomide—leprosy	0.00143	0.00842	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Dapsone—leprosy	0.00142	0.00839	CcSEcCtD
Oxcarbazepine—Bone disorder—Thalidomide—leprosy	0.00141	0.0083	CcSEcCtD
Oxcarbazepine—Viral infection—Thalidomide—leprosy	0.00141	0.0083	CcSEcCtD
Oxcarbazepine—Hypocalcaemia—Thalidomide—leprosy	0.00139	0.00819	CcSEcCtD
Oxcarbazepine—Thinking abnormal—Thalidomide—leprosy	0.00139	0.00819	CcSEcCtD
Oxcarbazepine—Atrioventricular block—Thalidomide—leprosy	0.00131	0.00773	CcSEcCtD
Oxcarbazepine—Sinusitis—Dapsone—leprosy	0.00131	0.00769	CcSEcCtD
Oxcarbazepine—Gait disturbance—Thalidomide—leprosy	0.0013	0.00768	CcSEcCtD
Oxcarbazepine—Blood uric acid increased—Thalidomide—leprosy	0.0013	0.00764	CcSEcCtD
Oxcarbazepine—Coordination abnormal—Thalidomide—leprosy	0.0013	0.00764	CcSEcCtD
Oxcarbazepine—Eructation—Thalidomide—leprosy	0.00125	0.00737	CcSEcCtD
Oxcarbazepine—Pharyngitis—Dapsone—leprosy	0.00124	0.0073	CcSEcCtD
Oxcarbazepine—Depressed level of consciousness—Thalidomide—leprosy	0.00123	0.00724	CcSEcCtD
Oxcarbazepine—Colitis—Thalidomide—leprosy	0.00122	0.0072	CcSEcCtD
Oxcarbazepine—Aplastic anaemia—Thalidomide—leprosy	0.0012	0.00704	CcSEcCtD
Oxcarbazepine—Tinnitus—Dapsone—leprosy	0.00116	0.00686	CcSEcCtD
Oxcarbazepine—Oesophagitis—Thalidomide—leprosy	0.00116	0.00685	CcSEcCtD
Oxcarbazepine—Rash maculo-papular—Thalidomide—leprosy	0.00116	0.00682	CcSEcCtD
Oxcarbazepine—Pulmonary oedema—Thalidomide—leprosy	0.00113	0.00667	CcSEcCtD
Oxcarbazepine—Hypertonia—Thalidomide—leprosy	0.00112	0.00657	CcSEcCtD
Oxcarbazepine—Hyperkinesia—Thalidomide—leprosy	0.00111	0.00654	CcSEcCtD
Oxcarbazepine—Mental disability—Thalidomide—leprosy	0.0011	0.00651	CcSEcCtD
Oxcarbazepine—Euphoric mood—Thalidomide—leprosy	0.00109	0.00644	CcSEcCtD
Oxcarbazepine—Lymphadenopathy—Thalidomide—leprosy	0.00108	0.00638	CcSEcCtD
Oxcarbazepine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00106	0.00626	CcSEcCtD
Oxcarbazepine—Vascular purpura—Thalidomide—leprosy	0.00103	0.00608	CcSEcCtD
Oxcarbazepine—Eczema—Thalidomide—leprosy	0.00103	0.00606	CcSEcCtD
Oxcarbazepine—Vision blurred—Dapsone—leprosy	0.00102	0.00603	CcSEcCtD
Oxcarbazepine—Libido decreased—Thalidomide—leprosy	0.000997	0.00587	CcSEcCtD
Oxcarbazepine—Amnesia—Thalidomide—leprosy	0.000984	0.00579	CcSEcCtD
Oxcarbazepine—Increased appetite—Thalidomide—leprosy	0.000984	0.00579	CcSEcCtD
Oxcarbazepine—Vertigo—Dapsone—leprosy	0.000977	0.00575	CcSEcCtD
Oxcarbazepine—Visual disturbance—Thalidomide—leprosy	0.000975	0.00574	CcSEcCtD
Oxcarbazepine—Purpura—Thalidomide—leprosy	0.000959	0.00565	CcSEcCtD
Oxcarbazepine—Cough—Dapsone—leprosy	0.000949	0.00559	CcSEcCtD
Oxcarbazepine—Hypoglycaemia—Thalidomide—leprosy	0.000947	0.00558	CcSEcCtD
Oxcarbazepine—Cardiac failure—Thalidomide—leprosy	0.000947	0.00558	CcSEcCtD
Oxcarbazepine—Lethargy—Thalidomide—leprosy	0.000943	0.00555	CcSEcCtD
Oxcarbazepine—Hyponatraemia—Thalidomide—leprosy	0.000928	0.00546	CcSEcCtD
Oxcarbazepine—Diplopia—Thalidomide—leprosy	0.000924	0.00544	CcSEcCtD
Oxcarbazepine—Pain in extremity—Thalidomide—leprosy	0.000924	0.00544	CcSEcCtD
Oxcarbazepine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000917	0.0054	CcSEcCtD
Oxcarbazepine—Migraine—Thalidomide—leprosy	0.00091	0.00536	CcSEcCtD
Oxcarbazepine—Affect lability—Thalidomide—leprosy	0.00091	0.00536	CcSEcCtD
Oxcarbazepine—Psychotic disorder—Thalidomide—leprosy	0.000903	0.00532	CcSEcCtD
Oxcarbazepine—Mood swings—Thalidomide—leprosy	0.000875	0.00516	CcSEcCtD
Oxcarbazepine—Ataxia—Thalidomide—leprosy	0.000869	0.00512	CcSEcCtD
Oxcarbazepine—Tachycardia—Dapsone—leprosy	0.000866	0.0051	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Thalidomide—leprosy	0.000853	0.00503	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Thalidomide—leprosy	0.000844	0.00497	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Thalidomide—leprosy	0.000841	0.00495	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000832	0.0049	CcSEcCtD
Oxcarbazepine—Muscular weakness—Thalidomide—leprosy	0.000815	0.0048	CcSEcCtD
Oxcarbazepine—Insomnia—Dapsone—leprosy	0.000803	0.00473	CcSEcCtD
Oxcarbazepine—Dysphagia—Thalidomide—leprosy	0.000799	0.0047	CcSEcCtD
Oxcarbazepine—Eosinophilia—Thalidomide—leprosy	0.000791	0.00466	CcSEcCtD
Oxcarbazepine—Bronchospasm—Thalidomide—leprosy	0.000786	0.00463	CcSEcCtD
Oxcarbazepine—Pancreatitis—Thalidomide—leprosy	0.000783	0.00461	CcSEcCtD
Oxcarbazepine—Bronchitis—Thalidomide—leprosy	0.000768	0.00452	CcSEcCtD
Oxcarbazepine—Pancytopenia—Thalidomide—leprosy	0.000759	0.00447	CcSEcCtD
Oxcarbazepine—Neutropenia—Thalidomide—leprosy	0.000747	0.0044	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Thalidomide—leprosy	0.000742	0.00437	CcSEcCtD
Oxcarbazepine—Pollakiuria—Thalidomide—leprosy	0.000738	0.00435	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Thalidomide—leprosy	0.000729	0.00429	CcSEcCtD
Oxcarbazepine—Weight increased—Thalidomide—leprosy	0.000727	0.00428	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Dapsone—leprosy	0.000726	0.00427	CcSEcCtD
Oxcarbazepine—Weight decreased—Thalidomide—leprosy	0.000723	0.00426	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Thalidomide—leprosy	0.000721	0.00424	CcSEcCtD
Oxcarbazepine—Pneumonia—Thalidomide—leprosy	0.000716	0.00422	CcSEcCtD
Oxcarbazepine—Infestation NOS—Thalidomide—leprosy	0.000712	0.00419	CcSEcCtD
Oxcarbazepine—Infestation—Thalidomide—leprosy	0.000712	0.00419	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000706	0.00416	CcSEcCtD
Oxcarbazepine—Abdominal pain—Dapsone—leprosy	0.000701	0.00413	CcSEcCtD
Oxcarbazepine—Body temperature increased—Dapsone—leprosy	0.000701	0.00413	CcSEcCtD
Oxcarbazepine—Renal failure—Thalidomide—leprosy	0.0007	0.00412	CcSEcCtD
Oxcarbazepine—Stomatitis—Thalidomide—leprosy	0.000694	0.00409	CcSEcCtD
Oxcarbazepine—Haematuria—Thalidomide—leprosy	0.000679	0.004	CcSEcCtD
Oxcarbazepine—Epistaxis—Thalidomide—leprosy	0.000672	0.00396	CcSEcCtD
Oxcarbazepine—Sinusitis—Thalidomide—leprosy	0.000668	0.00394	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Thalidomide—leprosy	0.000665	0.00391	CcSEcCtD
Oxcarbazepine—Bradycardia—Thalidomide—leprosy	0.000651	0.00383	CcSEcCtD
Oxcarbazepine—Rhinitis—Thalidomide—leprosy	0.000641	0.00378	CcSEcCtD
Oxcarbazepine—Hepatitis—Thalidomide—leprosy	0.000639	0.00377	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Thalidomide—leprosy	0.000636	0.00375	CcSEcCtD
Oxcarbazepine—Pharyngitis—Thalidomide—leprosy	0.000635	0.00374	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Thalidomide—leprosy	0.00063	0.00371	CcSEcCtD
Oxcarbazepine—Visual impairment—Thalidomide—leprosy	0.000616	0.00363	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Thalidomide—leprosy	0.000604	0.00356	CcSEcCtD
Oxcarbazepine—Eye disorder—Thalidomide—leprosy	0.000597	0.00352	CcSEcCtD
Oxcarbazepine—Tinnitus—Thalidomide—leprosy	0.000596	0.00351	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Thalidomide—leprosy	0.000593	0.00349	CcSEcCtD
Oxcarbazepine—Angiopathy—Thalidomide—leprosy	0.00058	0.00342	CcSEcCtD
Oxcarbazepine—Immune system disorder—Thalidomide—leprosy	0.000577	0.0034	CcSEcCtD
Oxcarbazepine—Chills—Thalidomide—leprosy	0.000574	0.00338	CcSEcCtD
Oxcarbazepine—Arrhythmia—Thalidomide—leprosy	0.000571	0.00336	CcSEcCtD
Oxcarbazepine—Alopecia—Thalidomide—leprosy	0.000565	0.00333	CcSEcCtD
Oxcarbazepine—Vomiting—Dapsone—leprosy	0.000564	0.00332	CcSEcCtD
Oxcarbazepine—Mental disorder—Thalidomide—leprosy	0.00056	0.0033	CcSEcCtD
Oxcarbazepine—Malnutrition—Thalidomide—leprosy	0.000557	0.00328	CcSEcCtD
Oxcarbazepine—Headache—Dapsone—leprosy	0.000556	0.00327	CcSEcCtD
Oxcarbazepine—Flatulence—Thalidomide—leprosy	0.000548	0.00323	CcSEcCtD
Oxcarbazepine—Tension—Thalidomide—leprosy	0.000546	0.00322	CcSEcCtD
Oxcarbazepine—Dysgeusia—Thalidomide—leprosy	0.000545	0.00321	CcSEcCtD
Oxcarbazepine—Nervousness—Thalidomide—leprosy	0.000541	0.00318	CcSEcCtD
Oxcarbazepine—Back pain—Thalidomide—leprosy	0.000538	0.00317	CcSEcCtD
Oxcarbazepine—Nausea—Dapsone—leprosy	0.000527	0.0031	CcSEcCtD
Oxcarbazepine—Vision blurred—Thalidomide—leprosy	0.000525	0.00309	CcSEcCtD
Oxcarbazepine—Tremor—Thalidomide—leprosy	0.000521	0.00307	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Thalidomide—leprosy	0.000516	0.00304	CcSEcCtD
Oxcarbazepine—Agitation—Thalidomide—leprosy	0.000511	0.00301	CcSEcCtD
Oxcarbazepine—Angioedema—Thalidomide—leprosy	0.000509	0.003	CcSEcCtD
Oxcarbazepine—Malaise—Thalidomide—leprosy	0.000502	0.00296	CcSEcCtD
Oxcarbazepine—Vertigo—Thalidomide—leprosy	0.0005	0.00295	CcSEcCtD
Oxcarbazepine—Syncope—Thalidomide—leprosy	0.000499	0.00294	CcSEcCtD
Oxcarbazepine—Leukopenia—Thalidomide—leprosy	0.000498	0.00293	CcSEcCtD
Oxcarbazepine—Palpitations—Thalidomide—leprosy	0.000492	0.0029	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Thalidomide—leprosy	0.000489	0.00288	CcSEcCtD
Oxcarbazepine—Cough—Thalidomide—leprosy	0.000486	0.00286	CcSEcCtD
Oxcarbazepine—Convulsion—Thalidomide—leprosy	0.000482	0.00284	CcSEcCtD
Oxcarbazepine—Hypertension—Thalidomide—leprosy	0.00048	0.00283	CcSEcCtD
Oxcarbazepine—Arthralgia—Thalidomide—leprosy	0.000474	0.00279	CcSEcCtD
Oxcarbazepine—Chest pain—Thalidomide—leprosy	0.000474	0.00279	CcSEcCtD
Oxcarbazepine—Myalgia—Thalidomide—leprosy	0.000474	0.00279	CcSEcCtD
Oxcarbazepine—Anxiety—Thalidomide—leprosy	0.000472	0.00278	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000471	0.00277	CcSEcCtD
Oxcarbazepine—Discomfort—Thalidomide—leprosy	0.000468	0.00276	CcSEcCtD
Oxcarbazepine—Dry mouth—Thalidomide—leprosy	0.000463	0.00273	CcSEcCtD
Oxcarbazepine—Confusional state—Thalidomide—leprosy	0.000458	0.0027	CcSEcCtD
Oxcarbazepine—Infection—Thalidomide—leprosy	0.000451	0.00266	CcSEcCtD
Oxcarbazepine—Shock—Thalidomide—leprosy	0.000447	0.00263	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Thalidomide—leprosy	0.000445	0.00262	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Thalidomide—leprosy	0.000445	0.00262	CcSEcCtD
Oxcarbazepine—Tachycardia—Thalidomide—leprosy	0.000443	0.00261	CcSEcCtD
Oxcarbazepine—Skin disorder—Thalidomide—leprosy	0.000441	0.0026	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Thalidomide—leprosy	0.000439	0.00259	CcSEcCtD
Oxcarbazepine—Anorexia—Thalidomide—leprosy	0.000433	0.00255	CcSEcCtD
Oxcarbazepine—Hypotension—Thalidomide—leprosy	0.000424	0.0025	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000414	0.00244	CcSEcCtD
Oxcarbazepine—Insomnia—Thalidomide—leprosy	0.000411	0.00242	CcSEcCtD
Oxcarbazepine—Dyspnoea—Thalidomide—leprosy	0.000405	0.00239	CcSEcCtD
Oxcarbazepine—Somnolence—Thalidomide—leprosy	0.000404	0.00238	CcSEcCtD
Oxcarbazepine—Dyspepsia—Thalidomide—leprosy	0.0004	0.00235	CcSEcCtD
Oxcarbazepine—Decreased appetite—Thalidomide—leprosy	0.000395	0.00233	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Thalidomide—leprosy	0.000392	0.00231	CcSEcCtD
Oxcarbazepine—Fatigue—Thalidomide—leprosy	0.000392	0.00231	CcSEcCtD
Oxcarbazepine—Constipation—Thalidomide—leprosy	0.000388	0.00229	CcSEcCtD
Oxcarbazepine—Pain—Thalidomide—leprosy	0.000388	0.00229	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Thalidomide—leprosy	0.000374	0.0022	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Thalidomide—leprosy	0.000371	0.00219	CcSEcCtD
Oxcarbazepine—Urticaria—Thalidomide—leprosy	0.000361	0.00213	CcSEcCtD
Oxcarbazepine—Abdominal pain—Thalidomide—leprosy	0.000359	0.00211	CcSEcCtD
Oxcarbazepine—Body temperature increased—Thalidomide—leprosy	0.000359	0.00211	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Thalidomide—leprosy	0.000335	0.00197	CcSEcCtD
Oxcarbazepine—Asthenia—Thalidomide—leprosy	0.000326	0.00192	CcSEcCtD
Oxcarbazepine—Pruritus—Thalidomide—leprosy	0.000321	0.00189	CcSEcCtD
Oxcarbazepine—Diarrhoea—Thalidomide—leprosy	0.000311	0.00183	CcSEcCtD
Oxcarbazepine—Dizziness—Thalidomide—leprosy	0.0003	0.00177	CcSEcCtD
Oxcarbazepine—Vomiting—Thalidomide—leprosy	0.000289	0.0017	CcSEcCtD
Oxcarbazepine—Rash—Thalidomide—leprosy	0.000286	0.00169	CcSEcCtD
Oxcarbazepine—Dermatitis—Thalidomide—leprosy	0.000286	0.00169	CcSEcCtD
Oxcarbazepine—Headache—Thalidomide—leprosy	0.000285	0.00168	CcSEcCtD
Oxcarbazepine—Nausea—Thalidomide—leprosy	0.00027	0.00159	CcSEcCtD
